Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-09 MAIN ALAN J EVP, Innov & Chem Sciences Grant or award · Restricted Stock Units +98,710 98,710
2023-02-09 MAIN ALAN J EVP, Innov & Chem Sciences Grant or award · Stock Option (Right to Buy) +296,130 296,130
2023-02-09 Kassler-Taub Kenneth B. SVP, Regulatory & QA Grant or award · Restricted Stock Units +98,270 98,270
2023-02-09 Kassler-Taub Kenneth B. SVP, Regulatory & QA Grant or award · Stock Option (Right to Buy) +294,810 294,810
2023-02-09 Granowitz Craig B SVP, Chief Medical Officer Grant or award · Restricted Stock Units +107,370 107,370
2023-02-09 Granowitz Craig B SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +322,110 322,110
2023-02-09 Crum Brian T SVP, General Counsel & Secr. Grant or award · Restricted Stock Units +100,370 100,370
2023-02-09 Crum Brian T SVP, General Counsel & Secr. Grant or award · Stock Option (Right to Buy) +301,100 301,100
2023-02-09 WADE JEFFREY L President and CFO Grant or award · Restricted Stock Units +147,340 147,340
2023-02-09 WADE JEFFREY L President and CFO Grant or award · Stock Option (Right to Buy) +442,030 442,030
2023-02-09 COATS LONNEL Chief Executive Officer Grant or award · Restricted Stock Units +361,150 361,150
2023-02-09 COATS LONNEL Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,083,440 1,083,440
2022-08-05 Invus US Partners LLC Director Purchase +147,390 $2.50 $368K 5,451,204
2022-08-05 Artal International S.C.A. Director Purchase +2,426,070 $2.50 $6.1M 50,859,331
2022-08-01 DEBBANE RAYMOND Director Purchase +982,600 $2.50 $2.5M 5,303,814
2022-08-01 Invus US Partners LLC Director Purchase +982,600 $2.50 $2.5M 5,303,814
2022-08-01 Artal International S.C.A. Director Purchase +16,173,800 $2.50 $40.4M 48,433,261
2022-05-21 Swain Judith L Director Grant or award · Stock Option (Right to Buy) +14,402 14,402
2022-05-21 Swain Judith L Director Grant or award · Restricted Stock Units +9,302 9,302
2022-05-21 SOBECKI CHRISTOPHER J Director Grant or award · Stock Option (Right to Buy) +14,402 14,402

Page 21 of 27 · 540 trades